↓ Skip to main content

Design and rationale of FOCUS (PX-171-011): A randomized, open-label, phase 3 study of carfilzomib versus best supportive care regimen in patients with relapsed and refractory multiple myeloma (R/R MM…

Overview of attention for article published in BMC Cancer, September 2012
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Above-average Attention Score compared to outputs of the same age and source (60th percentile)

Mentioned by

patent
1 patent

Citations

dimensions_citation
42 Dimensions

Readers on

mendeley
65 Mendeley
Title
Design and rationale of FOCUS (PX-171-011): A randomized, open-label, phase 3 study of carfilzomib versus best supportive care regimen in patients with relapsed and refractory multiple myeloma (R/R MM)
Published in
BMC Cancer, September 2012
DOI 10.1186/1471-2407-12-415
Pubmed ID
Authors

Roman Hájek, Richard Bryce, Sunhee Ro, Barbara Klencke, Heinz Ludwig

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 65 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 65 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 12 18%
Researcher 10 15%
Other 10 15%
Student > Master 6 9%
Student > Postgraduate 5 8%
Other 10 15%
Unknown 12 18%
Readers by discipline Count As %
Medicine and Dentistry 29 45%
Agricultural and Biological Sciences 6 9%
Nursing and Health Professions 4 6%
Psychology 4 6%
Biochemistry, Genetics and Molecular Biology 3 5%
Other 8 12%
Unknown 11 17%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 February 2015.
All research outputs
#7,550,194
of 23,033,713 outputs
Outputs from BMC Cancer
#2,097
of 8,365 outputs
Outputs of similar age
#56,721
of 171,319 outputs
Outputs of similar age from BMC Cancer
#29
of 93 outputs
Altmetric has tracked 23,033,713 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 8,365 research outputs from this source. They receive a mean Attention Score of 4.3. This one has gotten more attention than average, scoring higher than 68% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 171,319 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 48th percentile – i.e., 48% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 93 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 60% of its contemporaries.